Innventure, Inc. has entered into securities purchase agreements with four institutional investors for a registered direct offering that will generate approximately $40 million in gross proceeds. The company will sell 11,428,572 shares of common stock, with the offering expected to close around January 14, 2026, pending customary closing conditions. Titan Partners is serving as the sole placement agent for this transaction.
The net proceeds from this offering are allocated for specific corporate purposes. A significant portion will be used to repay all outstanding obligations under the company's convertible debentures dated September 15, 2025. Additionally, funds will support working capital and general corporate needs, which may include repayment of other indebtedness. Notably, the company plans to exercise its right to receive equity in Accelsius instead of cash for approximately $8 million in intercompany convertible debt and related interest repayment.
This capital infusion represents a strategic move for Innventure as it continues to execute its business model of building companies with billion-dollar valuations through commercializing breakthrough technology solutions. The company's approach systematically creates and operates industrial enterprises from inception, participating in early-stage economics while providing industrial operating expertise designed for global scale. According to company information available at https://www.innventure.com/, this methodology seeks to bridge what is often called the "Valley of Death" between corporate innovation and commercialization through value-driven multinational partnerships, operational experience, and capital-intensive scale-up expertise.
The registered direct offering structure allows companies to sell securities directly to institutional investors without a public offering, providing a more efficient capital raising mechanism. For Innventure, this $40 million transaction strengthens the company's financial position at a time when many industrial technology companies face challenges in securing growth capital. The decision to potentially convert debt to equity in Accelsius rather than seeking cash repayment suggests a strategic preference for maintaining ownership stakes in portfolio companies while managing corporate debt levels.
Industrial growth conglomerates like Innventure typically require substantial capital to scale operations and commercialize technologies across multiple ventures simultaneously. The $40 million raised through this offering provides the company with greater financial flexibility to pursue its stated objectives while addressing existing financial obligations. Market observers will monitor how these funds are deployed across Innventure's portfolio of industrial technology ventures and whether this capital injection accelerates the company's progress toward building what it describes as "billion-dollar valuations" for its created enterprises.
